Patents by Inventor Moo J. Sung

Moo J. Sung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds
    Publication number: 20110105496
    Abstract: This invention relates generally to methods for the treatment of myosin heavy chain (MyHC)-mediated conditions, and in particular, cardiovascular conditions.
    Type: Application
    Filed: December 19, 2006
    Publication date: May 5, 2011
    Inventors: Gabriel G. Gamber, Rishi K. Jain, Gary M. Ksander, Leslie W. McQuire, Lawrence S. Melvin, Moo J. Sung
  • 4,7-DIHYDROTHIENO[2,3-B]PYRIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
    Publication number: 20090306373
    Abstract: This invention relates generally to compounds and pharmaceutical compositions for the treatment of myosin heavy chain (MyHC)-mediated conditions, and in particular, cardiovascular conditions.
    Type: Application
    Filed: December 19, 2006
    Publication date: December 10, 2009
    Inventors: Gabriel G. Gamber, Rishi K. Jain, Gary M. Ksander, Leslie W. McQuire, Lawrence S. Melvin, Moo J. Sung
  • 3-substituted cephem compounds
    Patent number: 5336673
    Abstract: The present invention relates to novel cephalosporins of the formula (I); ##STR1## wherein, R.sub.1 represents a C.sub.1 .about.C.sub.4 alkyl group or ##STR2## wherein, R.sub.2 and R.sub.3, independently, represent hydrogen or a C.sub.1 .about.C.sub.3 alkyl group and R.sub.4 represents hydrogen or a C.sub.1 .about.C.sub.4 alkyl group;R.sub.1a represents hydrogen or an amino-protecting group;Q represents CH or N; andthe formula ##STR3## represents a saturated or unsaturated heterocyclic group which contains 1 to 4 nitrogen atoms of which one is substituted with an amino group to form quaternary ammonium, and oxygen or sulfur, or a fused heterocyclic group thereof formed together with a substituted or unsubstituted benzene or an optional heterocyclic group, or a pharmaceutically acceptable salt thereof, to processes for preparing the same and to a pharmaceutical composition containing the same as an active ingredient.
    Type: Grant
    Filed: February 26, 1992
    Date of Patent: August 9, 1994
    Assignee: Dae Woong Pharmaceutical Co., Ltd.
    Inventors: Chi J. Moon, Sae C. Park, Myoung G. Kim, Sea H. Oh, Seong S. Yim, Nam J. Park, Young K. Choi, Moo J. Sung